Results 71 to 80 of about 3,631 (165)

Malignant Prolactinoma Discovered by D2 Receptor Imaging [PDF]

, 2000
Patrick Pétrossians, Wouter W. de Herder, Dik J. Kwekkeboom, G. Lamberigts, Achille Stevenaert, Albert Beckers   +5 more
openalex   +2 more sources

Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas. [PDF]

, 1985
K. W. Hancock, J S Scott, J T Lamb, Robert Gibson, C. Chapman   +4 more
openalex   +1 more source

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma

JACC: Case Reports, 2020
We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD, Jeffrey Le, MD, Shivani Verma, MD, Benjamin A. Youdelman, MD   +3 more
doaj  

Mean platelet volume in patients with prolactinoma

Archives of Endocrinology and Metabolism, 2016
Objective Prolactin is a multifunctional pituitary hormone. The effect of prolactin on platelet activation is not well understood. Prolactinomas are the most common type of pituitary adenomas, and they are medically responsive to dopamine agonists. Mean
Abbas Ali Tam, Cafer Kaya, Hüsniye Başer, Reyhan Ersoy, Bekir Çakır   +4 more
doaj   +1 more source

Craniopharyngioma with hyperprolactinaemia due to a prolactinoma. [PDF]

, 1986
T Wheatley, J. David Clark, Sheila F. Stewart   +2 more
openalex   +1 more source

Massive prolactinoma with galactorrhoea in a prepubertal boy [PDF]

, 1989
R.J.M. Ross, J M McEniery, Ashley Grossman, I. Doniach, G. M. Besser, Martin O. Savage   +5 more
openalex   +1 more source

A "giant" prolactinoma [PDF]

, 1997
Uwe Reuter, S. Mehraein, G. Arnold, R. Lehmann   +3 more
openalex   +1 more source

Medical treatment of prolactinomas

Nature Reviews Endocrinology, 2011
Prolactinomas, the most prevalent type of neuroendocrine disease, account for approximately 40% of all pituitary adenomas. The most important clinical problems associated with prolactinomas are hypogonadism, infertility and hyposexuality. In patients with macroprolactinomas, mass effects, including visual field defects, headaches and neurological ...
COLAO, ANNAMARIA, SAVASTANO, SILVIA
openaire   +4 more sources

Prevalence of Autoimmune Thyroiditis and Other Autoimmune Diseases in Relation to Serum BAFF/APRIL Levels in Prolactinoma Patients

Gazi Medical Journal
Objective: There may be an association between hyperprolactinemia and autoimmune diseases, possibly because of the immunostimulatory effect of prolactin.
Özlem Kanburoğlu Meletli, Alev Altınova, Başak Bolayır, Resul Karakuş, Meriç Coşkun, Mehmet Muhittin Yalçın, Müjde Aktürk, İlhan Yetkin, Füsun Saadet Toruner   +8 more
doaj   +1 more source

Enhanced Slow Wave Sleep in Patients with Prolactinoma [PDF]

, 1998
R.-M. Frieboes
openalex   +1 more source